S Craigo

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

Bryan L. Roth, S Craigo, M S Choudhary et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 211 citations

Medicine, Pharmacology, Psychiatry +12

A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.

M S Choudhary, S Craigo, Bryan L. Roth · PubMed · 1993 · 118 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.

M S Choudhary, S Craigo, Bryan L. Roth · Molecular Pharmacology · 1992 · 48 citations

Medicine, Medicinal Chemistry, Pharmacology +16

A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.

M S Choudhary, S Craigo, Bryan L. Roth · Molecular Pharmacology · 1993 · 41 citations

Medicine, Molecular Biology, Pharmacology +12